Kenneth Fong Ph.D Overview
- Firm
- Kenson Ventures
- Primary Position
-
Founder & Chairm...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
0000
- Med. Valuation
-
000.0
Kenneth Fong Ph.D General Information
Biography
Dr. Kenneth Fong is the Founder and serves as Board Member at Kenson Ventures. Mr. Kenneth Fong is a Co-Founder and serves as Managing Director at System Biosciences. He also founded and serves as Chief Executive Officer at Takara Bio USA. Kenson specializes in venture financing and strategic consulting to biotech companies. Prior to founding Kenson, Dr. Fong is the founder and former CEO of CLONTECH Laboratories, that was acquired by Becton Dickinson (BD) in late 1999. CLONTECH is the leader in the Molecular/Cell Biology market and in the last 4 years before its acquisition, the company had experienced an average growth rate of 36% a year. The company also had 48 consecutive quarters of double-digit growth and profits. In 1994, 1995, 1998, and 1999, CLONTECH was selected as one of the fastest-growing companies in the San Francisco Bay Area. Dr. Fong's past experience is best suited to young companies and those desire to grow more rapidly. He is also adept at crafting development strategy and realistic implementation plan to promote the long-term growth of company. Dr. Fong obtained his Ph.D. from Indiana University. He also serves as the Chairman of the Board at Apexigen.
Contact Information
Address
- 401 Florence Street
- Suite 200
- Palo Alto, CA 94301
- United States
Kenneth Fong Ph.D Positions (3)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
DiagCor Bioscience | Company | Director | Hong Kong, Hong Kong | Diagnostic Equipment | |
Kenson Ventures | Investor | Founder & Chairman | Menlo Park, CA | Venture Capital | 0000-00-00 |
System Biosciences | Company | Co-Founder & Managing Director | Palo Alto, CA | Biotechnology | 0000-00-00 |
Kenneth Fong Ph.D Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Kenson Ventures | Menlo Park, CA | 0000-00-0 | |||
Turning Point Therapeutics | Drug Discovery | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | San Diego, CA | 0000-00-0 |
Kenneth Fong Ph.D Lead Partner on Deals (4)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Turning Point Therapeutics | 02-Jan-2014 | Early Stage VC (Series A) | 00.00 | Completed | Drug Discovery | San Diego, CA |
Apexigen | 08-Aug-2013 | 00000 00000 00 | 0000 | Completed | Drug Discovery | San Carlos, CA |
Diagnostic Hybrids | 11-Aug-2004 | Later Stage VC | 0000 | Completed | Diagnostic Equipment | Athens, OH |
Genewiz | Early Stage VC | Completed | Biotechnology | South Plainfield, NJ |
Kenneth Fong Ph.D Network (75)
Board Members (32)
Name | Company | Representing | Location | From |
---|---|---|---|---|
George Lee Ph.D | Turning Point Therapeutics | Self | San Diego, CA | |
Barbara Bodem | Turning Point Therapeutics | Self | San Diego, CA | 0000-00-00 |
000000 00 0 | Turning Point Therapeutics | Lilly Asia Ventures | San Diego, CA | 0000-00-00 |
00000 00000 | Apexigen | Self | San Carlos, CA | 0000-00-00 |
000000 0000 | Turning Point Therapeutics | Self | San Diego, CA | 0000-00-00 |
Portfolio Executives (43)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Kyri Van Hoose | Turning Point Therapeutics | Vice President | 02-Jan-2014 | San Diego, CA |
Annette North | Turning Point Therapeutics | Executive Vice President & General Counsel, Legal | 02-Jan-2014 | San Diego, CA |
0000 000 | Turning Point Therapeutics | Senior Vice President, Clinical Operations and Regulatory Affairs | 02-Jan-2014 | San Diego, CA |
00 000000 | Turning Point Therapeutics | Chief Financial Officer, Finance | 02-Jan-2014 | San Diego, CA |
000000 00 | Turning Point Therapeutics | Executive Vice President & Chief Commercial Officer | 02-Jan-2014 | San Diego, CA |
Kenneth Fong Ph.D FAQs
-
Who is Kenneth Fong Ph.D?
Dr. Kenneth Fong is the Founder and serves as Board Member at Kenson Ventures.
-
How much does Kenneth Fong Ph.D typically invest?
Kenneth Fong Ph.D's median deal size is 000000.
-
What is Kenneth Fong Ph.D’s main position?
Kenneth Fong Ph.D’s primary position is Founder & Chairman.
-
What are the contact details for Kenneth Fong Ph.D?
Kenneth Fong Ph.D’s email address is kfat.Duisaute@irured and his phone number is +1 (650) 000-0000.
-
How many active board seats does Kenneth Fong Ph.D hold?
Kenneth Fong Ph.D holds 2 board seats including Kenson Ventures and Turning Point Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »